Liang Shi

1.5k total citations
37 papers, 1.1k citations indexed

About

Liang Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Liang Shi has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Liang Shi's work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (17 papers) and RNA Research and Splicing (7 papers). Liang Shi is often cited by papers focused on RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (17 papers) and RNA Research and Splicing (7 papers). Liang Shi collaborates with scholars based in China, South Korea and Spain. Liang Shi's co-authors include Qiang Ding, Ji‐Fu Wei, Xinyuan Dai, Linling Lin, Li Yang, Shu‐Feng Zhou, Jing Wu, Hao Fan, Tiansong Xia and Xiaoxia Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Liang Shi

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang Shi China 22 906 569 108 91 51 37 1.1k
Jiang Shi China 14 619 0.7× 446 0.8× 75 0.7× 69 0.8× 46 0.9× 25 753
Yongqian Shu China 16 658 0.7× 347 0.6× 135 1.3× 88 1.0× 33 0.6× 22 773
Changye Zou China 18 901 1.0× 523 0.9× 189 1.8× 164 1.8× 44 0.9× 31 1.2k
Shunjie Xia China 9 534 0.6× 399 0.7× 86 0.8× 98 1.1× 68 1.3× 13 731
Chengtao Yu China 14 1.2k 1.3× 974 1.7× 72 0.7× 103 1.1× 64 1.3× 27 1.4k
Jieyi Ma China 20 1.1k 1.2× 656 1.2× 171 1.6× 117 1.3× 29 0.6× 37 1.3k
Wendi Hu China 14 835 0.9× 577 1.0× 141 1.3× 143 1.6× 30 0.6× 23 1.0k
Guosong Jiang China 15 651 0.7× 399 0.7× 110 1.0× 57 0.6× 34 0.7× 24 815
Chengyou Jia China 17 548 0.6× 395 0.7× 92 0.9× 86 0.9× 30 0.6× 45 766

Countries citing papers authored by Liang Shi

Since Specialization
Citations

This map shows the geographic impact of Liang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Shi more than expected).

Fields of papers citing papers by Liang Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Shi. The network helps show where Liang Shi may publish in the future.

Co-authorship network of co-authors of Liang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Shi. A scholar is included among the top collaborators of Liang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Shi. Liang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Shi, Liang, Han‐Dong Sun, Ziwen Wang, et al.. (2023). IGF2BP3 mediates the mRNA degradation of NF1 to promote triple‐negative breast cancer progression via an m6A‐dependent manner. Clinical and Translational Medicine. 13(9). e1427–e1427. 15 indexed citations
4.
Zhang, Duoteng, et al.. (2022). A light-activated magnetic bead strategy utilized in spatio-temporal controllable exosomes isolation. Frontiers in Bioengineering and Biotechnology. 10. 1006374–1006374. 7 indexed citations
5.
Li, Zhi, Xiaolan Zhang, Xu Zhang, et al.. (2022). Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 168–168. 35 indexed citations
6.
Cheng, Lin, Xu Zhang, Yuzhou Huang, et al.. (2021). Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway. Oncogenesis. 10(1). 7–7. 61 indexed citations
7.
8.
Li, Zhi, Haiyan Yang, Xinyuan Dai, et al.. (2021). CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression. International Journal of Biological Sciences. 17(5). 1178–1190. 50 indexed citations
9.
Chen, Wenhu, Li‐Fang Wang, Xiaoyan Li, et al.. (2021). LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma. Cell Death and Disease. 12(9). 806–806. 19 indexed citations
10.
Dai, Xinyuan, Liang Shi, Zhi Li, et al.. (2021). Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers. Frontiers in Oncology. 11. 635329–635329. 59 indexed citations
11.
Fan, Hao, Yugang Ge, Xiang Ma, et al.. (2020). Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer. Cell Death and Disease. 11(7). 521–521. 36 indexed citations
12.
Xiao, Jian, Linling Lin, Dakui Luo, et al.. (2020). Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance. Oncogenesis. 9(3). 29–29. 71 indexed citations
13.
Shi, Liang, Chao Yang, Yugang Ge, et al.. (2019). miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer. Cell Death and Disease. 10(1). 32–32. 67 indexed citations
14.
Zhu, Lei, Xiaoxia Li, Xi Sun, et al.. (2019). The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression. Journal of Experimental & Clinical Cancer Research. 38(1). 105–105. 37 indexed citations
15.
Sun, Xi, Yue Hu, Jing Wu, et al.. (2018). RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 298–298. 37 indexed citations
16.
Zhou, Shu‐Feng, Jing Wu, Liang Shi, et al.. (2017). PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 149–149. 80 indexed citations
17.
Wu, Jing, Shu‐Feng Zhou, Xi Sun, et al.. (2017). RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer. British Journal of Cancer. 117(5). 675–684. 39 indexed citations
18.
Shi, Liang, et al.. (2015). Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA.. PubMed. 8(9). 10662–70. 27 indexed citations
19.
Cheng, Lin, Tiansong Xia, Yifen Wang, et al.. (2014). The Apoptotic Effect of D Rhamnose β-Hederin, a Novel Oleanane-Type Triterpenoid Saponin on Breast Cancer Cells. PLoS ONE. 9(3). e90848–e90848. 33 indexed citations
20.
Xia, Tiansong, Wenbin Zhou, Lin Cheng, et al.. (2014). RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer. BMC Cancer. 14(1). 322–322. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang Shi Breakdown of academic impact, for papers by Yongqian Shu Breakdown of academic impact, for papers by Changye Zou Breakdown of academic impact, for papers by Shunjie Xia Breakdown of academic impact, for papers by Chengtao Yu Breakdown of academic impact, for papers by Jieyi Ma Breakdown of academic impact, for papers by Wendi Hu Breakdown of academic impact, for papers by Guosong Jiang Breakdown of academic impact, for papers by Chengyou Jia
Rankless by CCL
2026